| Bioactivity | (Gly22)-amyloid beta-protein(1-40) (Arctic variant Ab40ARC (E22G)) is a peptide. (Gly22)-amyloid beta-protein(1-40) can be used for the research of Alzheimer's disease[1]. |
| Name | (Gly22)-amyloid beta-protein(1-40) |
| CAS | 175010-18-1 |
| Sequence | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
| Shortening | DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV |
| Formula | C191H291N53O56S |
| Molar Mass | 4257.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lashuel HA, et al. Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores. J Mol Biol. 2003 Sep 26;332(4):795-808. |
(Gly22)-amyloid beta-protein(1-40)
CAS: 175010-18-1 F: C191H291N53O56S W: 4257.74
(Gly22)-amyloid beta-protein(1-40) (Arctic variant Ab40ARC (E22G)) is a peptide. (Gly22)-amyloid beta-protein(1-40) can
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.